← Eichor
Study identifier: NCT06221306 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Crestal Bone Loss Around Narrow Diameter Implants Versus Standard Diameter Implants With Bone Augmentation in Horizontally Deficient Posterior Mandibular Sites.

Condition: Horizontal Atrophy of Edentulous Alveolar Ridge  ·  Sponsor: Cairo University

PhaseNA
Planned participants28
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Dental implant treatment, in many cases, may be impeded by anatomical limitations, such as narrow atrophic ridges. In order to overcome that, additional surgical procedures, such as guided bone regeneration, are often required to augment the deficient hard tissue. However, additional surgical procedures often add morbidity to the patient in addition to prolonging the treatment time and raising the treatment cost. Hence, simpler, less invasive treatment options are preferred by patients. The use of narrow diameter implants (NDI) offers the great advantage of eliminating the need for augmentation procedures.

This description comes directly from the study's public registry record.

Talk to the study team

Suzy Naiem, MSc  ·  +201224785645  ·  suzy.naiem@gmail.com

Hani El Nahass, Professor  ·  +201000252603  ·  hani.elnahass@dentistry.cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniversityCairo, Greater Cairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06221306